Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.790
+0.100 (5.92%)
At close: Aug 13, 2025, 4:00 PM
1.780
-0.010 (-0.56%)
Pre-market: Aug 14, 2025, 8:26 AM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $152.49 million as of August 14, 2025. Its market cap has increased by 99.65% in one year.
Market Cap
152.49M
Enterprise Value
156.29M
1-Year Change
99.65%
Ranking
Category
Stock Price
1.79
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $152.49M, an increase of 69.03%. That is a compound annual growth rate of 21.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 152.49M | 85.32% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |